CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: hydroperoxy polyunsaturated fatty acid
Accession: CHEBI:189832
browse the term
Definition: Any polyunsaturated fatty acid carrying one or more hydroperoxy substituents.
Synonyms: related_synonym: Formula=CH2O4R; SMILES=OO[*]C(O)=O; hydroperoxy polyunsaturated fatty acids
cyclic_relationship: is_conjugate_acid_of CHEBI:134019
G
Gpx1
glutathione peroxidase 1
increases response to substance
ISO
GPX1 protein results in increased susceptibility to 12-HPETE
CTD
PMID:11115402
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx4
glutathione peroxidase 4
increases chemical synthesis
ISO
GPX4 protein results in increased chemical synthesis of 12-HPETE
CTD
PMID:11115402
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
12-HPETE inhibits the reaction [Sodium Salicylate inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid]]; 12-HPETE inhibits the reaction [Sodium Salicylate results in decreased activity of PTGS2 protein]
CTD
PMID:12538810
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Cat
catalase
increases expression
ISO
13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of CAT protein
CTD
PMID:10946007
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
increases expression
ISO
13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of CAV1 mRNA
CTD
PMID:27257344
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
EXP
[13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of CCL2 mRNA; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of CCL2 protein; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of CCL2 mRNA; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of CCL2 protein
CTD
PMID:22135674
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Egr1
early growth response 1
multiple interactions
EXP
[13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of EGR1 mRNA; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of EGR1 protein; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of EGR1 mRNA; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of EGR1 protein
CTD
PMID:22135674
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Ppara
peroxisome proliferator activated receptor alpha
increases expression
EXP
13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of PPARA protein
CTD
PMID:22135674
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
EXP
13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of PPARG protein
CTD
PMID:22135674
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ephx3
epoxide hydrolase 3
multiple interactions
ISO
[EPHX3 gene mutant form results in decreased hydrolysis of Epoxy Compounds] results in decreased abundance of [9,10,13-trihydroxy-11-octadecenoic acid binds to Ceramides]; [EPHX3 gene mutant form results in decreased hydrolysis of Epoxy Compounds] which results in decreased chemical synthesis of 9,10,13-trihydroxy-11-octadecenoic acid
CTD
PMID:33334892
NCBI chr 7:11,206,812...11,212,122
Ensembl chr 7:11,206,812...11,212,122
G
Agt
angiotensinogen
multiple interactions increases lipidation
ISO
Ascorbic Acid promotes the reaction [linoleic acid hydroperoxide results in increased lipidation of AGT protein modified form]
CTD
PMID:26111765
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Cygb
cytoglobin
increases metabolic processing
EXP
CYGB protein results in increased metabolism of linoleic acid hydroperoxide
CTD
PMID:11320098
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
G
Gpx1
glutathione peroxidase 1
increases reduction
ISO
GPX1 protein results in increased reduction of linoleic acid hydroperoxide
CTD
PMID:8428933
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
increases reduction
ISO
GPX2 protein results in increased reduction of linoleic acid hydroperoxide
CTD
PMID:8428933
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19808
chemical entity
19806
atom
19806
nonmetal atom
19744
carbon atom
19702
organic molecular entity
19702
lipid
17957
fatty acid
16792
unsaturated fatty acid
1095
hydroperoxy unsaturated fatty acid
13
hydroperoxy polyunsaturated fatty acid
13
(10E,12Z)-9-Hydroperoxy-10,12-octadecadienoic acid
0
(15S)-hydroperoxy-(11Z,13E)-icosadienoic acid
0
(4Z,7Z,10Z,13Z,15E,17R,19Z)-17-hydroperoxydocosahexaenoic acid
0
(4Z,7Z,10Z,13Z,15E,17S,19Z)-17-hydroperoxydocosahexaenoic acid
0
(4Z,7Z,11E,13Z,16Z,19Z)-10-hydroperoxydocosahexaenoic acid
0
(4Z,7Z,11Z,13Z,15E,17S,19Z)-10,17-bis(hydroperoxy)docosahexaenoic acid
0
(5Z,9E,11Z,14Z,17Z)-8-hydroperoxyicosapentaenoic acid +
0
(7S,14S)-bis(hydroperoxy)-(4Z,8E,10Z,12E,16Z,19Z)-docosahexaenoic acid
0
(7S,17S)-bis(hydroperoxy)-(4Z,8E,10Z,13Z,15E,19Z)-docosahexaenoic acid
0
(8E,10S,12Z,15Z)-10-hydroperoxyoctadeca-8,12,15-trienoic acid
0
(8E,12Z)-10-hydroperoxy-8,12-octadecadienoic acid +
0
(9Z,11E)-9-hydroperoxyoctadeca-9,11-dienoic acid
0
11-HpETE
0
12-HPE(8,10,14)TrE +
0
13-Hpotre(R)
0
13-hydroperoxylinoleic acid
0
13S-HpOTrE(gamma)
0
2R-HpOTrE
0
4(S)-hydroperoxy-17(R)-hydroxydocosahexaenoic acid
0
4(S)-hydroperoxy-17(S)-hydroxydocosahexaenoic acid
0
4-(5'-((1E,3E,6Z,9Z)-dodeca-1,3,6,9-tetraen-1-yl)-[3,3'-bi(1,2-dioxolan)]-5-yl)-4-hydroperoxybutanoic acid
0
5,12-DiHPETE
0
5,15-DiHPETE
0
5-Hydroperoxyeicosatetraenoic acid
0
5-hydroperoxy-7-[3,5-epidioxy-2-(2-octenyl)-cyclopentyl]-6-heptenoic acid
0
7(S)-hydroperoxy-17(R)-hydroxydocosahexaenoic acid
0
8,15-DiHPETE
0
9-HpOTrE
0
E,E-13-HpODE
0
E,E-9-HpODE
0
HPETE +
3
HPODE +
11
bis(hydroperoxy)icosatetraenoic acid +
0
hydroperoxy(epoxy)icosatrienoic acid +
0
hydroperoxy(hydroxy)icosapentaenoic acid +
0
hydroperoxy(hydroxy)icosatetraenoic acid +
0
hydroperoxydocosahexaenoic acid +
0
hydroperoxydocosapentaenoic acid +
0
hydroperoxyicosapentaenoic acid +
0
hydroperoxyicosatrienoic acid +
0
hydroperoxyoctadecatrienoic acid +
0
prostaglandin G3
0
Path 2
CHEBI ontology
19808
subatomic particle
19806
composite particle
19806
hadron
19806
baryon
19806
nucleon
19806
atomic nucleus
19806
atom
19806
main group element atom
19756
p-block element atom
19756
carbon group element atom
19705
carbon atom
19702
organic molecular entity
19702
heteroorganic entity
19460
organochalcogen compound
19224
organooxygen compound
19141
carbon oxoacid
18612
carboxylic acid
18609
monocarboxylic acid
17984
fatty acid
16792
unsaturated fatty acid
1095
hydroperoxy unsaturated fatty acid
13
hydroperoxy polyunsaturated fatty acid
13
(10E,12Z)-9-Hydroperoxy-10,12-octadecadienoic acid
0
(15S)-hydroperoxy-(11Z,13E)-icosadienoic acid
0
(4Z,7Z,10Z,13Z,15E,17R,19Z)-17-hydroperoxydocosahexaenoic acid
0
(4Z,7Z,10Z,13Z,15E,17S,19Z)-17-hydroperoxydocosahexaenoic acid
0
(4Z,7Z,11E,13Z,16Z,19Z)-10-hydroperoxydocosahexaenoic acid
0
(4Z,7Z,11Z,13Z,15E,17S,19Z)-10,17-bis(hydroperoxy)docosahexaenoic acid
0
(5Z,9E,11Z,14Z,17Z)-8-hydroperoxyicosapentaenoic acid +
0
(7S,14S)-bis(hydroperoxy)-(4Z,8E,10Z,12E,16Z,19Z)-docosahexaenoic acid
0
(7S,17S)-bis(hydroperoxy)-(4Z,8E,10Z,13Z,15E,19Z)-docosahexaenoic acid
0
(8E,10S,12Z,15Z)-10-hydroperoxyoctadeca-8,12,15-trienoic acid
0
(8E,12Z)-10-hydroperoxy-8,12-octadecadienoic acid +
0
(9Z,11E)-9-hydroperoxyoctadeca-9,11-dienoic acid
0
11-HpETE
0
12-HPE(8,10,14)TrE +
0
13-Hpotre(R)
0
13-hydroperoxylinoleic acid
0
13S-HpOTrE(gamma)
0
2R-HpOTrE
0
4(S)-hydroperoxy-17(R)-hydroxydocosahexaenoic acid
0
4(S)-hydroperoxy-17(S)-hydroxydocosahexaenoic acid
0
4-(5'-((1E,3E,6Z,9Z)-dodeca-1,3,6,9-tetraen-1-yl)-[3,3'-bi(1,2-dioxolan)]-5-yl)-4-hydroperoxybutanoic acid
0
5,12-DiHPETE
0
5,15-DiHPETE
0
5-Hydroperoxyeicosatetraenoic acid
0
5-hydroperoxy-7-[3,5-epidioxy-2-(2-octenyl)-cyclopentyl]-6-heptenoic acid
0
7(S)-hydroperoxy-17(R)-hydroxydocosahexaenoic acid
0
8,15-DiHPETE
0
9-HpOTrE
0
E,E-13-HpODE
0
E,E-9-HpODE
0
HPETE +
3
HPODE +
11
bis(hydroperoxy)icosatetraenoic acid +
0
hydroperoxy(epoxy)icosatrienoic acid +
0
hydroperoxy(hydroxy)icosapentaenoic acid +
0
hydroperoxy(hydroxy)icosatetraenoic acid +
0
hydroperoxydocosahexaenoic acid +
0
hydroperoxydocosapentaenoic acid +
0
hydroperoxyicosapentaenoic acid +
0
hydroperoxyicosatrienoic acid +
0
hydroperoxyoctadecatrienoic acid +
0
prostaglandin G3
0